Andrew Keith Stewart, MBChB, MRCP, FRCPC, MBA, obtained his medical degree at Aberdeen University Medical School in the UK. He completed his residency in internal medicine at Queen’s University and obtained a fellowship in hematology at the University of Toronto. Dr Stewart further completed a fellowship in medical research council (MRC) at the New England Medical Center in Boston, Massachusetts.
Dr Stewart is currently a consultant in the Division of Hematology and Oncology at the Mayo Clinic in Arizona, and serves as a Director of the Mayo Clinic Center for Individualized Medicine.
Speaking on individualized treatment of multiple myeloma
Dr Stewart’s research is centred around genomics and the individualized treatment of multiple myeloma. He has spent over two decades undertaking funded research for the integration of genomics in targeted treatments in myeloma.
Dr Stewart’s efforts in leading clinical trials and new drugs in hematologic cancers has had a large impact in many scientific journals and won him numerous awards including being named as the Scott‐Whitmore Chair in Hematology and Gene Therapy and one of Canada’s ‘Top 40 under 40’.